Nurami Medical
Modernizing Soft Tissue Repair
StartupNurami Medical is a Haifa-based startup in the Health Tech & Life Sciences sector, established in 2014. Modernizing Soft Tissue Repair. The company has raised a total of $43.65M across 9 funding rounds, currently at the B stage. Nurami Medical was founded by Amir Bahar and Nora Nseir. Key investors include NGT HealthCare II, Iron Nation, Almeda Ventures, among 11 total investors. The company has 11-50 employees. Core technologies: Materials & Substances, Nanomaterials, Polymers, Implants.
With $43.65M in total funding, Nurami Medical is a B-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageB
- ProductClinical Trial
- ModelB2B
- Employees11-50
- HQHaifa
- DistrictNorth District
- Last Round$30M
- NGT HealthCare II
- Iron Nation
- Almeda VenturesLead
11 investors total
Amir BaharCo-Founder, COO & Clinical Director
Nora NseirCo-founder, Inventor, BOD, R&D Director
8 articles covered by sources including www.calcalistech.com,
www.prnewswire.com,
finance.walla.co.il,
en.globes.co.il,
bloomer.co.il.
What does Nurami Medical do?
Nurami harnesses nanofibers and novel biomaterials to modernize soft tissue surgical repair. Nurami’s proprietary, electrospun-based platform technology enables the creation of an innovative category of bio surgical implants to seal and heal wounds effectively. These advanced products address complications associated with current soft tissue implants, such as dangerous leaks, and promote healthy tissue formation such as Dura repair as well as other tissue recovery processes. Nurami's first soft-tissue repair product, ArtiFascia, is a multilayer, Dural repair graft made of biocompatible and bioabsorbable polymers with integrated barrier layer and a biomimetic structure of electrospun fibers designed to promote neodura regeneration. ArtiFascia is available for commercial use in the USA and has FDA 510(k) clearance.
How much funding has Nurami Medical raised?
Nurami Medical has raised $43.65M in total funding across 9 rounds. The company is currently at the B stage. Key investors include NGT HealthCare II, Iron Nation, Almeda Ventures.
Who founded Nurami Medical?
Nurami Medical was founded in 2014 by Amir Bahar (Co-Founder, COO & Clinical Director), Nora Nseir (Co-founder, Inventor, BOD, R&D Director).
What sector is Nurami Medical in?
Nurami Medical operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Biomaterials & Tissue Engineering, Medical Devices, Medical Treatment & Therapeutics, with core technologies in Materials & Substances, Nanomaterials, Polymers, Implants. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Life Sciences, Biotechnology.
Where is Nurami Medical located?
Nurami Medical is based in Ha-Namal Street 36, Haifa, Israel, North District.